Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1981 3
1982 4
1983 1
1984 2
1985 5
1986 3
1987 6
1988 6
1989 8
1990 4
1991 6
1992 5
1993 4
1994 4
1995 7
1996 4
1997 4
1998 8
1999 5
2000 1
2001 4
2002 8
2003 6
2004 7
2005 7
2006 3
2007 5
2008 12
2009 12
2010 13
2011 12
2012 14
2013 13
2014 13
2015 19
2016 20
2017 19
2018 18
2019 25
2020 16
2021 14
2022 7
2023 14
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

350 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators. Morschhauser F, et al. N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104. N Engl J Med. 2018. PMID: 30184451 Free PMC article. Clinical Trial.
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, Bairey O, Hillmen P, Bartlett NL, Li J, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre S, Quach H, Gaidano G, Maslyak Z, Stevens DA, Janssens A, Offner F, Mayer J, O'Dwyer M, Hellmann A, Schuh A, Siddiqi T, Polliack A, Tam CS, Suri D, Cheng M, Clow F, Styles L, James DF, Kipps TJ; RESONATE-2 Investigators. Burger JA, et al. N Engl J Med. 2015 Dec 17;373(25):2425-37. doi: 10.1056/NEJMoa1509388. Epub 2015 Dec 6. N Engl J Med. 2015. PMID: 26639149 Free PMC article. Clinical Trial.
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet.
Ribrag V, Bron D, Rymkiewicz G, Hoelzer D, Jørgensen J, de Armas-Castellano A, Trujillo-Martín M, Fenaux P, Malcovati L, Bolaños N, Ribera JM, Herbaux C, Sarkozy C, Zinzani PL, Walewski J, Chamuleau MED. Ribrag V, et al. Among authors: bron d. Lancet Haematol. 2025 Feb;12(2):e138-e150. doi: 10.1016/S2352-3026(24)00351-X. Lancet Haematol. 2025. PMID: 39909657 Review.
Aviation Cardiology.
Syburra T, von Wattenwyl R, Bron D, Nicol E. Syburra T, et al. Among authors: bron d. Eur Heart J. 2019 Jul 1;40(25):1998-2000. doi: 10.1093/eurheartj/ehz418. Eur Heart J. 2019. PMID: 31259376 No abstract available.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group. Prince HM, et al. Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7. Lancet. 2017. PMID: 28600132
Hepatosplenic T-cell lymphoma: treatment challenges.
Bron D, De Leval L, Michiels S, Wittnebel S; EuroBloodNet for rare diseases. Bron D, et al. Curr Opin Oncol. 2021 Sep 1;33(5):406-411. doi: 10.1097/CCO.0000000000000775. Curr Opin Oncol. 2021. PMID: 34409955 Review.
Congenital heart disease in aircrew.
Nicol ED, Manen O, Guettler N, Bron D, Davenport ED, Syburra T, Gray G, d'Arcy J, Rienks R. Nicol ED, et al. Among authors: bron d. Heart. 2019 Jan;105(Suppl 1):s64-s69. doi: 10.1136/heartjnl-2018-313059. Heart. 2019. PMID: 30425088 Free PMC article. Review.
Aging and malignant hemopathies.
Bron D, Ades L, Fulop T, Goede V. Bron D, et al. Haematologica. 2015 May;100(5):571-4. doi: 10.3324/haematol.2014.117721. Haematologica. 2015. PMID: 25944637 Free PMC article. No abstract available.
Multicultural approaches of cancer pain.
Crombez P, Bron D, Michiels S. Crombez P, et al. Among authors: bron d. Curr Opin Oncol. 2019 Jul;31(4):268-274. doi: 10.1097/CCO.0000000000000547. Curr Opin Oncol. 2019. PMID: 31169591 Review.
350 results